Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
Clinical trial NCT02268604 · TERMINATED
Trial details
- NCT number
- NCT02268604
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.